<DOC>
	<DOCNO>NCT00120081</DOCNO>
	<brief_summary>The primary objective clinical trial determine safety tolerability Na-ASP-2 Hookworm Vaccine healthy subject follow administration 3 intramuscular ( IM ) injection vaccine 16 week use 3 different dos . The secondary objective make preliminary evaluation immunogenicity 3 dos vaccine healthy volunteer .</brief_summary>
	<brief_title>Study Na-ASP-2 Human Hookworm Vaccine Healthy Adults Without Evidence Hookworm Infection</brief_title>
	<detailed_description>There urgent need new tool control human hookworm infection reduce burden disease develop country . This especially true child woman reproductive age represent population highly vulnerable effect hookworm disease . Up 65,000 death annually attribute human hookworm infection . However , mortality estimate hookworm pale comparison global disease burden estimate . The primary approach hookworm control worldwide frequent periodic use benzimidazole anthelminthic school-age child . However , school-based anthelminthic chemotherapy program miss population highly vulnerable hookworm , include adolescent adult woman . In addition , high rate hookworm re-infection occur within 4-12 month follow anthelminthic chemotherapy , evidence diminish efficacy benzimidazoles frequent periodic use , possibly emerge drug resistance . These concern prompt interest develop alternative tool hookworm control . Vaccination prevent high intensity hookworm infection would alleviate public health deficiency drug treatment alone .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hookworm Infections</mesh_term>
	<mesh_term>Ancylostomiasis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<criteria>Healthy adult 18 45 year age . Signed informed consent . History , physical exam , laboratory test indicate good general health obtain prior first injection . All female must negative pregnancy test ( FDAapproved test β human chorionic gonadotropin [ βHCG ] ) day first injection . Serologic test human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus ( HCV ) negative screening . All subject must agree use acceptable method birth control start screen 2 week third injection . Acceptable method female subject include hormonal contraceptive , intrauterine device ( IUD ) , diaphragm spermicide , condom , abstinence , surgically sterile ( hysterectomy ) , surgically sterile partner . Acceptable method male subject include surgical sterilization , condom , partner us acceptable method birth control , abstinence . Any history anaphylaxis allergy vaccine component allergy insect sting , include bee sting . A past current history hookworm infection . BMI &lt; 18.0 &gt; 30.0 . Recent ( &lt; 72 hour ) history febrile illness time vaccination ( temperature &gt; 99.6°F equivalent ) . Received immune globulin blood product 3 month prior injection schedule within 4 week thereafter . Had vaccination live virus vaccine within 4 week receipt vaccine schedule within 4 week thereafter . Had vaccination kill vaccine , allergy treatment antigen injection within 14 day initial study injection . Received investigational agent within 4 week initial study injection . Known suspected impairment immunologic function include , limited clinically significant liver disease , diabetes mellitus , moderate severe kidney impairment ( creatinine &gt; 1.5 ) , history malignancy ( except squamous cell basal cell skin cancer ) , HIV infection autoimmune disease , concomitant immunosuppressive medication glucocorticosteroids . A history essential hypertension , gastrointestinal abnormality peptic ulcer disease , cardiac ( ECG abnormality ) , pulmonary , hepatic , renal , pancreatic , neurologic disease . Taken prescription medication exception subject stable regimen ( &gt; 30 day ) : ( 1 ) hormone replacement therapy , ( 2 ) use nasal steroid , ( 3 ) topical therapy , ( 4 ) certain class antidepressant ( i.e. , selective serotonin reuptake inhibitor ) , ( 5 ) oral contraceptive , ( 6 ) nonsteroidal antiinflammatory agent , ( 7 ) antihistamine decongestant seasonal allergy take need . Contraindication IM injection anticoagulant therapy thrombocytopenia . Pregnant , nursing , expect conceive study . Any history chronic alcohol drug abuse current treatment know prescribed overthecounter supplement may hepatotoxins . Any subject , Investigator 's opinion , unable adhere protocol requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Hookworm</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Human Hookworm Infection</keyword>
	<keyword>Na-ASP-2</keyword>
</DOC>